Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular Huntingtons disease

• 收藏
• 分享

专利权人:

Teva Pharmaceutical Industries Ltd.

发明人:

Hayden, Michael,Fitzer-Attas, Cheryl

申请号：

AU2013323133

公开号：

AU2013323133A1

申请日:

2013.09.27

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

This invention provides a method of treating a patient afflicted with a neurodegenerative disorder, e.g., Huntingtons disease, comprising administering to the patient rasagiline as an add-on therapy to or in combination with pridopidine. This invention also provides a package and a pharmaceutical composition comprising rasagiline and pridopidine for treating a patient afflicted with a neurodegenerative disorder. This invention also provides rasagiline for use as an add-on therapy or in combination with pridopidine in treating a patient afflicted with a neurodegenerative disorder. This invention further provides use of rasagiline and pridopidine in the preparation of a combination for treating a patient afflicted with a neurodegenerative disorder.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/